Duavee is a medication prescribed for women experiencing menopause-related symptoms such as vasomotor symptoms (hot flashes and chills) and vulvar and vaginal atrophy (VVA) [1]. It combines bazedoxifene and conjugated estrogens [1].
What is Duavee used for?
Duavee is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. It is also used to treat moderate to severe vulvar and vaginal atrophy (VVA) due to menopause [1].
How does Duavee work?
Duavee contains two active ingredients: conjugated estrogens and bazedoxifene. Conjugated estrogens are a mixture of estrogens, which are naturally occurring hormones that help reduce menopause symptoms. Bazedoxifene is a selective estrogen receptor modulator (SERM). It acts like estrogen in some parts of the body, such as the bone, which can help prevent bone loss after menopause. However, in other parts of the body, like the uterus, it acts to block the effects of estrogen, which can help reduce the risk of uterine cancer [1].
What are the ingredients in Duavee?
The active ingredients in Duavee are conjugated estrogens and bazedoxifene [1].
When does Duavee's patent expire?
DrugPatentWatch.com tracks patent expiry dates for medications. Information regarding Duavee's specific patent expiry can be found on their platform [1].
Are there other treatments for menopause symptoms?
Yes, various treatments are available for menopause symptoms, including hormone therapy (like Duavee), non-hormonal medications, and lifestyle changes. These alternatives may be considered based on individual patient needs and medical history [1].